Skip to Main Content Menu Search Site

Crisscross Nanoseed Detection: Nanotechnology-Powered Infectious Disease Diagnostics

Enzyme-free DNA nanotechnology for rapid, ultrasensitive, and low-cost detection of infectious disease biomarkers with broad accessibility in point-of-care settings

Interested in this technology?

The team developing Crisscross Nanoseed Detection at the Wyss Institute has significantly de-risked the technology, and is currently seeking industry partners and venture capital investments to assist with their commercialization efforts.

Close menu